As the team described in a poster presented at a conference at Rowan University Virtua Health College of Medicine & Life ...

The patient was diagnosed with drug rash with eosinophilia and systemic symptoms (DRESS) syndrome secondary to vancomycin. He had eight points on the scoring system developed by the European Registry ...

Ivarmacitinib, also known as oral SHR0302, is not yet approved by the FDA, with trials currently exploring its utility in ...